关注
Bradford A Moffat
Bradford A Moffat
Melbourne Brain Centre Imaging Unit, University of Melbourne, Australia
在 unimelb.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors
B Chertok, BA Moffat, AE David, F Yu, C Bergemann, BD Ross, VC Yang
Biomaterials 29 (4), 487-496, 2008
11332008
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response
BA Moffat, TL Chenevert, TS Lawrence, CR Meyer, TD Johnson, Q Dong, ...
Proceedings of the national academy of sciences 102 (15), 5524-5529, 2005
8002005
Vascular targeted nanoparticles for imaging and treatment of brain tumors
GR Reddy, MS Bhojani, P McConville, J Moody, BA Moffat, DE Hall, ...
Clinical Cancer Research 12 (22), 6677-6686, 2006
6152006
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma
DA Hamstra, TL Chenevert, BA Moffat, TD Johnson, CR Meyer, ...
Proceedings of the National Academy of Sciences 102 (46), 16759-16764, 2005
3722005
Evaluation of cancer therapy using diffusion magnetic resonance imaging
BD Ross, BA Moffat, TS Lawrence, SK Mukherji, SS Gebarski, DJ Quint, ...
Molecular cancer therapeutics 2 (6), 581-587, 2003
3182003
Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity
TJ Oxley, NL Opie, SE John, GS Rind, SM Ronayne, TL Wheeler, JW Judy, ...
Nature Biotechnology, 2016
2822016
Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer
R Kopelman, YEL Koo, M Philbert, BA Moffat, GR Reddy, P McConville, ...
Journal of Magnetism and Magnetic Materials 293 (1), 404-410, 2005
2322005
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome
BA Moffat, TL Chenevert, CR Meyer, PE Mckeever, DE Hall, BA Hoff, ...
Neoplasia 8 (4), 259-267, 2006
2302006
A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI
BA Moffat, GR Reddy, P McConville, DE Hall, TL Chenevert, ...
Molecular imaging 2 (4), 15353500200303163, 2003
2062003
Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy
TL Chenevert, CR Meyer, BA Moffat, A Rehemtulla, SK Mukherji, ...
Molecular imaging 1 (4), 15353500200221482, 2002
1762002
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of …
CJ Galbán, SK Mukherji, TL Chenevert, CR Meyer, DA Hamstra, ...
Translational oncology 2 (3), 184-190, 2009
1682009
Diffusion imaging for evaluation of tumor therapies in preclinical animal models
BA Moffat, DE Hall, J Stojanovska, PJ McConville, JB Moody, ...
Magnetic Resonance Materials in Physics, Biology and Medicine 17, 249-259, 2004
1602004
Age-related changes in refractive index distribution and power of the human lens as measured by magnetic resonance micro-imaging in vitro
BA Moffat, DA Atchison, JM Pope
Vision research 42 (13), 1683-1693, 2002
1572002
Age-related changes in the kinetics of water transport in normal human lenses
BA Moffat, KA Landman, RJW Truscott, MHJ Sweeney, JM Pope
Experimental eye research 69 (6), 663-669, 1999
1571999
Comparative study of the magnetic behavior of spherical and cubic superparamagnetic iron oxide nanoparticles
G Zhen, BW Muir, BA Moffat, P Harbour, KS Murray, B Moubaraki, ...
The Journal of Physical Chemistry C 115 (2), 327-334, 2011
1472011
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy
KC Lee, BA Moffat, AF Schott, R Layman, S Ellingworth, R Juliar, AP Khan, ...
Clinical cancer research 13 (2), 443-450, 2007
1272007
Systematic review: quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases
P Ravanfar, SM Loi, WT Syeda, TE Van Rheenen, AI Bush, P Desmond, ...
Frontiers in neuroscience 15, 618435, 2021
1182021
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies
DA Hamstra, KC Lee, JM Tychewicz, VD Schepkin, BA Moffat, M Chen, ...
Molecular Therapy 10 (5), 916-928, 2004
1162004
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker
DE Hall, BA Moffat, J Stojanovska, TD Johnson, Z Li, DA Hamstra, ...
Clinical cancer research 10 (23), 7852-7859, 2004
1062004
A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information
CR Meyer, BA Moffat, KK Kuszpit, PL Bland, PE Mckeever, TD Johnson, ...
Molecular imaging 5 (1), 7290.2006. 00002, 2006
932006
系统目前无法执行此操作,请稍后再试。
文章 1–20